How ISO 13485 Safeguards Full-Lifecycle Safety Of RF Puncture Needles
May 29, 2026
For medical devices, especially those deployed in high-risk areas such as the heart, reliability must be underpinned by standardized management systems rather than chance. Every RF transseptal puncture needle manufactured by Manners Technology is governed throughout its entire lifecycle - from raw material intake to final sterilization and packaging - under the stringent frameworks of ISO 13485:2016 (Medical Devices Quality Management System) and ISO 9001:2015. These systems ensure not only conformance during final inspection, but also predictability, controllability and full traceability across every production stage.
Phase 1: Design and Development Control - Starting with Risk Analysis
Quality management commences upon receiving customized requirements from clients such as Baylis Medical or initiating independent product development. Manners Technology's engineering team conducts systematic design input reviews and risk analysis in compliance with ISO 14971. Typical assessments include: whether the diameter and hardness of the needle body can withstand designated pushing force without bending; whether the radius of the blunt tip delivers stable tissue contact while avoiding excessive tissue compression; and how to set electropolishing parameters to achieve consistent surface finish without altering critical dimensions.
All conclusions are documented in formal design outputs, including engineering drawings, process specifications and Bill of Materials (BOM), together with dedicated Verification and Validation (V&V) plans.
Phase 2: Procurement and Incoming Material Control - Securing Quality at the Source
Quality originates from raw materials. Manners Technology implements rigorous supplier qualification audits for stainless steel bar stock vendors. Every material batch is accompanied by complete Material Test Certificates (MTC) covering chemical composition, mechanical properties and traceability codes. Random sampling and testing are conducted prior to warehousing to verify compliance with medical-grade 304/305 stainless steel standards. Non-conforming materials are quarantined and returned immediately to eliminate potential risks at the source.
Phase 3: Production and Process Control - Governing Every Micron with Data
Real-time monitoring and recording of Critical Process Parameters (CPP) are core requirements of ISO 13485 on the production line.
- Citizen R04 lathe: Spindle speed, feed rate, tool offset parameters and coolant conditions are fully logged to maintain stable machining performance.
- Electropolishing tank: Electrolyte temperature, concentration, current density and processing duration are strictly regulated to ensure uniform surface treatment across all batches.
- Ultrasonic cleaning unit: Detergent formulation, temperature, ultrasonic frequency, power and cleaning duration follow standardized protocols.
- These process parameters are correlated with Critical Quality Attributes (CQA) such as dimensional accuracy, surface roughness and cleanliness via Statistical Process Control (SPC) charts. This enables proactive quality control instead of merely screening defective products after production.
Phase 4: Inspection, Testing and Release - Multi-Level Checks with Zero Oversight
Finished products must pass a full set of release tests:
- Dimensional inspection: High-precision optical measuring instruments and profile projectors are adopted for 100% inspection or AQL sampling on diameter, length, taper and other dimensions, ensuring compliance with the tolerance of ±0.01 mm.
- Surface inspection: The needle body, particularly the tip, is examined under magnifiers or microscopes to rule out scratches, burrs, pits and other defects.
- Performance testing: For RF puncture needles, electrical continuity and insulation resistance tests are performed where applicable, to guarantee safe and accurate energy transmission.
- Cleanliness and particulate testing: Regular cleaning validation is carried out on finished products to detect insoluble particles and bacterial endotoxins, meeting the criteria for sterile medical devices.
- Packaging and sterilization validation: Final packaging such as PP pouches and sterilization processes including ethylene oxide (EO) sterilization undergo rigorous validation to sustain product sterility throughout the shelf life.
Phase 5: Traceability and Continuous Improvement
Each individual needle and production batch is assigned a unique identification code. Full traceability is available to track back to raw material batches, production equipment, operators and process parameters, as well as track forward to end customers. In the event of quality incidents, the impact scope can be quickly identified and contained.
Meanwhile, production data, inspection records and customer feedback are collected to drive the Corrective and Preventive Action (CAPA) cycle for continuous improvement, steadily elevating product quality and process capability.
Conclusion
Manners Technology's ISO 13485 quality system acts as an invisible yet robust quality safeguard network. It ensures every RF transseptal puncture needle is a reliable output of standardized, scientific and repeatable workflows, rather than a coincidentally qualified product. This system certification serves as a far more valuable credential than the product itself, building solid trust for clinicians and patients.








